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Echocardiographic predictive factors of short-term poor outcomes
after transcatheter aortic valve implantation
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Boulmier (1), Marcel Laurent (1), Jean-Philippe Verhoye (1), Herve
Le Breton (1)
(1) CHU de Rennes – Hôpital Pontchaillou, Centre cardio-pneumologi-
que, Rennes Cedex 09, France – (2) CHU Rennes, département de cardio-
logie, Rennes, France
Background: Patients’ selection for TAVI remains a major concern given
the large amount of patients who do not improve after this procedure.
Methods: 99 consecutive patients undergoing TAVI at the university hos-
pital of Rennes were included in a registry and prospectively followed at 6-
month. The study population was divided into two groups: “good outcomes”
(GO) vs “bad outcomes” (BO), according to the occurrence of death from any
cause, acute heart failure (AHF) or coronary syndrome (ACS), stroke and 6-
month NYHA functional class (Class I/II vs III/IV). The patients’ clinical,
biological and echocardiographic characteristics were studied to find predic-
tive factors of BO.
Results: Forty patients met the criteria of the BO group. The mean (± SD) age
of the GO and BO groups was 77.8 (11.6) and 81.5 (5.5) years respectively
(p=.06). Patients in the BO group had a higher Society of Thoracic Surgeon Score
(p=.016), had more history of chronic obstructive/restrictive pulmonary disease
(p=.03), of atrial fibrillation (p=.004) and less history of thoracic radiotherapy
(p=.03). Univariate analysis identified the following pre operative echocardio-
graphic criteria as being linked to BO: left atrial area (LAA) on 4 chamber apical
view (p=.0016), mitral and tricuspid regurgitation ≥ grade 2 (p=.008 and.001
respectively) and a sytolic pulmonary arterial pressure ≥60 mm Hg (p=.02). In a
multivariate model combining these features, LAA remained the sole PF of BO
(p=.039, relative risk (95% confidence interval) = 1.1[1.004-1.169])
Conclusion: Our results suggest that a careful assessment of diastolic func-
tion is useful when evaluating a patient for TAVI and should be taken into
account in patients’ selection.
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Transcatheter aortic valve implantation in patients with Hodgkin’s
lymphoma
Aziza Touati, David Messika-Zeitoun
Hôpital Bichat, cardiologie, Paris, France
Objectives: Transcatheter aortic valve implantation (TAVI) has emerged
as a valuable alternative to surgical aortic valve replacement with promising
results for patients with severe aortic stenosis (AS) considered as being at high
or prohibitive surgical risk. Results in the high-risk subgroup of patients with
post-radiation AS was unknown.
Methods: From October 2006 to June 2011, among the 272 patients who
underwent a TAVI at our institution, 12 had post-radiation AS due to
Hodgkin’s lymphoma and 260 had degenerative AS. Complications were
assessed according to VARC definitions.
Results: Post-radiation AS patients were younger (61±11 vs. 83±7 years,
p<0.0001), had a lower Euroscore were (9±9% vs. 25±13%, p=0.0003) but
presented more frequently with porcelain aorta (60% vs. 13%, p<0.0001).
TAVI results and complications are presented in the Table. In the post-radia-
tion AS, mortality rate was not significantly different (one death due to a
severe sepsis) but there was less complications especially a lower rate of
major vascular complications, hospital duration was shorter and patients more
frequently discharged at home.
Conclusions: Among AS patients who underwent a TAVI, post-radia-
tion patients experienced a lower rate of complications than patients with
degenerative AS. In regard to the high mortality and morbidity of conven-
tional surgery, our results suggest that TAVI may be an elective indication
for post-radiation AS patients but deserve further confirmation in larger
series.
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Comparison of primary pacemaker implantations in the following
transcatheter aortic valve implantation (TAVI) in the University
Hospital of Clermont Ferrand, according to two types of valve
Charles Vorilhon (1), Géraud Souteyrand (1), Nicolas Durel (1), Andrea
Innorta (2), Jean Paul Chadefaux (1), Jean René Lusson (1)
(1) CHU Gabriel Montpied, cardiologie et maladie vasculaire, Clermont
Ferrand, France – (2) CHU Gabriel Montpied, chirurgie cardiaque et
thoracique, Clermont Ferrand, France
Introduction: Aortic valve replacement is the definitive therapy for severe
aortic stenosis (valve area<0.6cm²/m²). Elderly and the associated comorbidity
represent an operative risk (estimated with the EuroSCORE). TAVI is an
alternative to surgery or balloon valvuloplasty. Two valves were marketed:
Edwards and CoreValve. The complications of TAVI are well known and sim-
ilar for the both. Only the primary pacemaker implantations (PPI) are greater
with CoreValves. The objectives are to compare the PPI after a TAVI in the
CHU of Clermont Ferrand depending on the type of valve, then to explain this
difference. Method: We used the register FRANCE II to a retrospective anal-
ysis of all patients with a TAVI in the CHU of Clermont Ferrand. We only
excluded patients who died within 24 hours post procedure and patients who
were already a pacemaker. The search for a PPI, age, type of valve, diameter
of the valve, surgical approach, presence of bundle branch block (BB), oper-
ator dependence and learning curve were analyzed. Results: From January
2010 to March 2012, 78 were included in this study (66% of CoreValve and
34% of Edwards). Of the 22 PPI (22.9%), 100% complicated a Corevalve
(p=0.00034). Age, operator, learning curve, surgical approach and diameter of
the valve are not risk factors for PPI, in contrast to the presence of BB
(p=0.025). 
Conclusion: This study confirms that CoreValves are more complicated
PPI than Edwards. The presence of BB is a risk factor for primary implanta-
tion. The lack of power of this study does not reveal other risk factors such as
the diameter of the valve or the learning curve effect.. 
Characteristics 
of the patients
GO N=59 BO N=40 p value
Society of Thoracic Surgeon 
Score
5.9±3.1 7.5±3.2 0.016
NYHA class-no. 
(% of total no.)
4 (10.0) 0.03
I or II 15 (25.4) 36 (90.0) 0.004
III or IV 44 (74.6) 2 (5.0) 0.9
Thoracic radiotherapy-no. 
(% of total no.)
12 (20.3) 23 (57.5) 0.002
Baseline NT pro-BNP-pg/mL 4442.9±4829.9 5338.8±4850.2
6 months – NT 
pro-BNP-pg/mL
1349.4±1276.0 3937.3±5761.5
ECHO Baseline
LV EF% 48.2±15.1 51.2±13.3 0.31
Aortic valve area-cm2 0.66±0.15 0.71±0.17 0.15
Mean aortic valve 
gradient-mm Hg
50.3±16.2 46.0±12.7 0.16
Mitral valve regurgitation ≥ grade 
2-no. (% of total no.)
18 (30.5) 23 (57.5) 0.0075
Left atrial area-cm2 25.9±7.0 30.6±6.1 0.0016
Tricuspid valve regurgitation ≥ 
grade 2-no. (% of total no.)
7 (11.9) 16 (40.0) 0.001
6 months follow-up
LV-EF% 54.4±10.2 53.6±10.3 0.75
Aortic valve area-cm2 1.82±0.5 1.92±0.75 0.48
Systolic pulmonary arterial pressure 
> Hg-no. (% of total no.)
3 (5.3) 5 ± (19.2) 0.046
